Jiménez VJ, Horta LCP, Saavedra VHA, Morán MJ

Language: Spanish
References: 25
Page:
PDF size: 369.16 Kb.

ABSTRACT

Introduction: Hypertensive pregnancy status is one of the obstetrical most important unsolved problems. Pregnancy can induce specific tensional elevation and kidney damage. There have been some studies describing changes in blood pressure throughout pregnancy. In countries where prenatal care is not adequate, preeclampsia causes 40 and 80 % of maternal deaths. 50 000 deaths per year are estimated.
Objective: Evaluate how the evolution of blood pressure in the immediate postpartum period in patients undergoing curettage procedure is presented due to pregnancyinduced hypertensive disease.
Methods: A comparative study with an intervention group and a control group was conductedat "Dr. Joaquin del Valle Sánchez" University Hospital, in Torreon, Coahuila, Mexico. The intervention consisted of carrying out the process of trans-cesarean curettage in patients with pregnancy-induced hypertensive disease. The main readings were the analysis of medical records, complete biochemical profile, and pressure figures.
Result: Most patients who come to the service of Gynecology and Obstetrics are teenagers 14-20 years. There was significant improvement in systolic blood pressure at 8 and 16 h, and decreased to 24 in systolic and diastolic blood pressure in patients undergoing the procedure of curettage.
Conclusions: The use of curettage procedure after cesarean section in patients with hypertensive disease induced by pregnancy significantly lowers blood pressure. The use of this procedure is suggested in patients undergoing cesarean section at suggested "Dr. Joaquín del Valle Sánchez" University Hospital and other health centers.

REFERENCES

1. OMS. Trends in maternal mortality. 1990 to 2010. Ginebra; 2012.

2. Nieves MC. Hypertension and Pregnancy. Hipertens Riesg Vasc. 2011;28(5-6):167- 8.

3. Meenakshi S, Mauchumi SP, Anindita P. A Study on Atherogenic Indices of Pregnancy Induced Hypertension Patients as Compared to Normal Pregnant Women. J Clin Diagn Res. 2015;9(7):BC05-BC08.

4. Cooray SD, Edmonds SM, Tong S, Samarasekera SP, Whitehead CL. Characterization of Symptoms Immediately Preceding Eclampsia. Obstet Gynecol. 2011;118(5):995-9.

5. Guía de práctica clínica. Enfermedades Hipertensivas del embarazo. Rev Med Inst Mex Seguro Soc. 2011;49(2):213-24.

6. Monica M, Mufuta T, Gombe TN, Donewell B and Prosper C. Prevalence of pregnancy induced hypertension and pregnancy outcomes among women seeking maternity services in Harare, Zimbabwe. BMC Cardiovascular Disorders. 2015;15:111.

7. Cande VA, Katherine MK, Ronald JW. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013;347:6564.

8. Villar J, Guillermo C, Daniel W, Edgardo A, Daniel G, Hassan Ba’aqeel. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol. 2006;194:921-31.

9. Sánchez R, Nava S, Moran C, Moreno JF, Cerbon CM, Estado actual de la preeclampsia en México: de lo epidemiológico a sus mecanismos moleculares. Rev Invest Clin. 2010;62(3):252-60.

10. Osmany B, Irene T. Human decidual stroma cell express HLA-G Effects of citokines and decidualization. Hum Reprod. 2008;23(1):144-52.

11. Barbara S, Ioannis M. Expression of endothelial NO sythase, inducible NO synthase, and estrogen receptors alfa and beta placental tissue of normal preclamptic and intrauterine growthrestricted pregnancies. J Histochem Cytochem. 2005;53(12):1441-9.

12. Cortés PS, Milán PF, Gobernado TJA, Mora CP. Epidemiología de los estados hipertensivos del embarazo. Clin Invest Gin Obst. 2009;36(4):132-9.

13. Marshall D, Lindheimer A, Sandra JT, Gary CF. Hypertension in pregnancy. J Am Soc Hypertens. 2008;2(6):484-94.

14. Christine LR, Charles SA, Jonathan MM, Jane BF and David JHS. Hypertensive disorders in pregnancy: a population-based study. MJA. 2005;182:332-5.

15. Alkan A, Tugrul S. Effects of postpartum uterine curettage on maternal well-being in severe preeclamptic patients. Obstet Gynecol. 2006;81(4):55-8.

16. Seal SL, Ghosh D, Kamilya G, y cols. Does route of delivery affect maternal and perinatal outcome in women with eclampsia? A randomized controlled pilot study. Am J Obstet Gynecol. 2012;206:484:1-7.

17. Assis TR, Viana FP, Rassi S. Study on the major maternal risk factors in hypertensive syndromes. Arq Bras Cardiol. 2008;91:11-7.

18. Callaway LK, McIntyre HD, O’Callaghan M, Williams GM, Najman JM, Lawlor DA. The association of hypertensive disorders of pregnancy with weight gain over the subsequent 21 years: Findings from a prospective cohort study. Am J Epidemiol. 2007;166:421-8.

19. Santos-Bolivar J, Guerra-Velasquez M. Legrado uterino o nifedipina durante el postparto en pacientes con preeclampsia severa. Rev Obstet Ginecol Venez. 2011;71(4):240-5.

20. Ahmed HET AA, Raouf M. Nabil El-Tabbakh, Samir FAA. Effect of Immediate Postpartum Curettage on the Recovery of Severe Preeclampsia. Ob Gyn Pathology Dept Al-zhar. 2011.

21. Ragab A, Goda H, Raghib M, Barakat R, El-Samanoudy A, Badawy A. Does inmmediate postpartum curettage of the endometriumm accelerate recovery from preeclansia? A randomized crontrolled trial. Arch Gynecol Obtetric. 2013;288(5):1035- 8.

22. Ottoniel V, Belkis C. Legrado uterino como terapia coadyuvante en el tratamiento de preeclampsia severa. Rev Obstet Ginecol Venez. 2007;67(2).

23. Kathleen A, Pennington, Schlitt J. Preeclampsia: Multiple Approages for a multifactorial disease. Dis Model Mech. 2012;5:9-18.

24. Jennifer LB, Sherri AL, Xiaozhang J, Alfred GR. Does Dilation and Curettage Affect Future Pregnancy Outcomes? Ochsner Journal. 2007;7:173-6.

25. Briseño Pérez C, Briseño Sanabria L. Conducta obstétrica basada en evidencias. Preeclampsia leve; manejo expectante ¿Hospitalario o ambulatorio? Ginecol Obstet Mex. 2006;74:537-45.